169 patents
Page 3 of 9
Utility
Heterocyclic compounds and their use for treatment of helminthic infections and diseases
22 Nov 22
Natalie Hawryluk, Stacie S. Canan, Kevin R. Condroski, Graham Kyne, Matthew Bedore, Sanjay Menon
Filed: 24 Apr 20
Utility
Method of Determining the Identity And/or Amount of an ANTI-IL-31 Antibody In a Sample
17 Nov 22
The present invention provides a method of determining the identity and/or amount of an anti-IL-31 antibody in a sample.
Gary Francis Bammert, Steven Alan Dunham
Filed: 28 Jul 22
Utility
Ehrlichia Vaccines and Immunogenic Compositions
10 Nov 22
Provided herein are immunogenic compositions that may be used, in some aspects, to induce an immune response against an Ehrlichia such as Ehrlichia cams.
Jere W. McBRIDE, Paul J. DOMINOWSKI, Suman MAHAN, Jason J. MILLERSHIP, Duncan M. MWANGI, Sharath RAI, Sharon M. WAPPEL
Filed: 13 Jul 20
Utility
Medicament Delivery System, and Associated Method
20 Oct 22
An intra-orifice medicament delivery system and formation method involve a housing defining an inner chamber extending along a longitudinal axis, with the chamber wall defining one or more openings therethrough.
Susan Leers Sucheta, Nicholas Alan Wicks, Derrick Scott Sjodin, Christopher Jeremy Block, Laibin Luo
Filed: 17 Feb 22
Utility
Lateral flow test system
18 Oct 22
A lateral flow test system having an optical reader, a lateral flow cartridge and a computer system is provided.
Carl Esben Poulsen, Johan Eriksen, Martin Heller, Niels Kristian Bau-Madsen
Filed: 9 Mar 18
Utility
Endoparasitic Depsipeptides
13 Oct 22
Todd Maddux, Matthew W. Bedore, Paul D. Johnson, Tomasz Respondek, Susan M.K. Sheehan, Graham M. Kyne, Richard A. Ewin, Rajendran Vairagoundar, Michael P. Curtis
Filed: 7 May 19
Utility
Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
11 Oct 22
The invention relates to recombinant viral vectors for the insertion and expression of foreign genes for use in safe immunizations to protect against a variety of pathogens.
Sing Rong, Yugang Luo, Tyler Brown
Filed: 10 Sep 20
Utility
North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
29 Sep 22
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory CALVERT, David Ewell SLADE, Siao-Kun W. WELCH
Filed: 6 Jun 22
Utility
Lyophilization methods that provide stably dehydrated protozoans for use as potent live vaccines
27 Sep 22
An improved stabilization buffer for use in the lyophilization of Neospora and other protozoans is disclosed.
Rim Daoussi, Frederick H. Weber
Filed: 4 Oct 17
Utility
Mycoplasma Bovis Compositions
22 Sep 22
Disclosed herein are Mycoplasma bovis immunogenic compositions useful in raising an immune response in animals against M. bovis.
Glenn Francis Browning, Philip Francis Markham, Marc Serge Marenda, Fred H. Weber, Suman Mahan
Filed: 6 Jun 22
Utility
Effective Vaccination Against Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Prior to Weaning
22 Sep 22
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory Calvert, Robert G. Ankenbauer, Jacqueline Gayle Marx, Douglas S. Pearce, Marcia L. Keith
Filed: 6 Jun 22
Utility
Veterinary compositions for use in treating mastitis, and associated methods
20 Sep 22
The present disclosure relates generally to sol-gel polymer composites that comprise chitosan, a hydrophilic polymer, a polysiloxane, and a gelation agent in a suitable medium.
Christina Lee Brown, Derek James Sheehan, John Mark Heimlich, Todd Foster, Jeffrey Ellis Price, Sumitra Rajagopalan, Alexandre Therrien, Oscar Suarez, Nicholas Finn Cunningham
Filed: 19 Apr 18
Utility
Peptide vaccines against interleukin-31
6 Sep 22
A vaccine composition for immunizing and/or protecting a mammal against an IL-31 mediated disorder is provided, wherein the composition includes: the combination of a carrier polypeptide and at least one mimotope selected from a feline IL-31 mimotope, a canine IL-31 mimotope, a horse IL-31 mimotope, and a human IL-31 mimotope; and an adjuvant.
Gary Francis Bammert, Steven Alan Dunham
Filed: 18 Mar 19
Utility
Horse IL-31 Induced Pruritus Model
1 Sep 22
The present invention provides an IL-31 horse pruritus model which confirms that IL-31 induces itch in horses and can be used to assess whether certain test compounds can block or reduce the itch in treated horses.
Elizabeth A. VanBeelen, Andrea J. Gonzales, Timothy J. Fleck, Katelyn S. Vroman, Gary F. Bammert
Filed: 18 Feb 22
Utility
Microfluidic assay system, a microfluidic cartridge and a method of performing an assay
2 Aug 22
Niels Kristian Bau-Madsen, Bent Overby
Filed: 31 Jan 17
Utility
Unknown
19 Jul 22
Disclosed herein are Mycoplasma bovis immunogenic compositions useful in raising an immune response in animals against M. bovis.
Glenn Francis Browning, Philip Francis Markham, Marc Serge Marenda, Fred H. Weber, Suman Mahan
Filed: 11 Aug 16
Utility
Antibodies to Canine and Feline Oncostatin M Receptor Beta and Uses Thereof
9 Jun 22
The invention provides an isolated antibody, or antigen-binding portion thereof that specifically binds to canine or feline Oncostatin M receptor Beta (OSMR-β) or both, wherein the antibody antagonizes IL-31-mediated signaling or OSM-mediated signaling or both in a canine and/or feline cell.
Gary Francis Bammert, Andrea Joy Gonzales
Filed: 18 Oct 21
Utility
Vaccine Against Infectious Bronchitis
9 Jun 22
Poultry vaccines against infectious bronchitis and Turkey Rhinotracheitis are provided.
Carla Maria Batista de Freitas, Maria Carolina Ferreira dos Santos, Paul Joseph Dominowski, Harmen Jacob Geerligs
Filed: 13 Jul 21
Utility
Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning
7 Jun 22
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory Calvert, Robert G. Ankenbauer, Jacqueline Gayle Marx, Douglas S. Pearce, Marcia L. Keith
Filed: 2 Aug 19
Utility
North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
7 Jun 22
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory Calvert, David Ewell Slade, Siao-Kun W. Welch
Filed: 4 Mar 20